Memorial Sloan Kettering Cancer Center Receives Highly Competitive NCI SPORE Grant for Leukemia Research with a Focus on Acute Myeloid Leukemia

The National Cancer Institute (NCI) recently awarded Memorial Sloan Kettering Cancer Center (MSK) with a prestigious Specialized Programs of Research Excellence (SPORE) grant for leukemia research. The Translational Research Program (TRP) is the home of the SPOREs — a cornerstone of NCI’s efforts to promote collaborative, interdisciplinary translational cancer research.